Protease inhibitors enhance levodopa effects in Parkinson's disease

Mov Disord. 1999 May;14(3):535. doi: 10.1002/1531-8257(199905)14:3<535::aid-mds1034>3.0.co;2-s.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / metabolism*
  • Drug Synergism
  • Dyskinesia, Drug-Induced / etiology*
  • HIV Protease Inhibitors / pharmacology*
  • Humans
  • Indinavir / pharmacology*
  • Levodopa / adverse effects*
  • Levodopa / metabolism*
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • HIV Protease Inhibitors
  • Levodopa
  • Indinavir